Radiation and Cancer Biology

Radiation and Cancer Biology

SS 39 - Biology 7 - Special Session: Innovative Biologic Approaches to Improve Risk Stratification and Treatment Outcomes

10/24/2018
1:30 PM - 3:00 PM
Location: Room 206

Session Type: Scientific
1.50 AMA PRA Category 1 Credits™
1.50 CAMPEP Credits

Presentations:

ViewAttendees 6 CE Eval

Freddy Escorcia, MD, PhD

Disclosure:
Employment
Area 23: Medical Strategy Director: Employee; National Institutes of Health: Assistant Clinical Investigator: Employee

Ownership
Novartis: Stock

Biography:
Freddy E Escorcia, MD, PhD, is an Assistant Clinical Investigator and Radiation Oncologist within the Molecular Imaging Program, Center for Cancer Research at the National Cancer Institute. He leads the Laboratory of Molecular Radiotherapy which is focused on engineering tumor-selective molecular probes for imaging and treating human cancers, with particular interest in hepatobiliary malignancies.

Presentation(s):

ViewAttendees 6 CE Eval

Send Email for Freddy Escorcia

Scott Bratman, MD, PhD

Princess Margaret Hospital

Disclosure:
Employment
University Health Network: Staff Radiation Oncologist - Clinician Scientist: Employee

Ownership
Inventor on patent: Patent/License Fees/Copyright

Biography:
Dr. Scott Bratman is an Assistant Professor of Radiation Oncology and Medical Biophysics at the University of Toronto and a Scientist at the Princess Margaret Cancer Research Institute. He also serves as Clinician-Scientist in the Radiation Medicine Program at The Princess Margaret Cancer Centre. Dr. Bratman was trained at Princeton University, Columbia University Medical Center, and Stanford Cancer Institute. At Stanford he performed postdoctoral research studies with Drs. Max Diehn and Ash Alizadeh and published a landmark study on liquid biopsies for lung cancer patients. Since moving to Toronto in 2014, his research and clinical focus has been on head and neck cancer. The Bratman Lab is currently developing and validating new liquid biopsy tools for detecting the presence of cancer. The team is also interested in genomic tools and other biomarkers for personalized use of radiotherapy for head and neck cancer patients.

Presentation(s):

ViewAttendees 6 CE Eval

Send Email for Scott Bratman


Assets

SS 39 - Biology 7 - Special Session: Innovative Biologic Approaches to Improve Risk Stratification and Treatment Outcomes



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for SS 39 - Biology 7 - Special Session: Innovative Biologic Approaches to Improve Risk Stratification and Treatment Outcomes